37 results match your criteria: "Universitets-sjukhuset[Affiliation]"
Lakartidningen
June 2024
docent, överläkare, VO infektionssjukdomar, Akademiska sjukhuset, Uppsala, Referensgruppen för antibiotikafrågor (RAF).
Lakartidningen
July 2023
senior professor, överläkare, institutionen för strålningsvetenskaper, onkologi, Umeå universitet; Cancercentrum, Norrlands universitetssjukhus.
The standard treatment of glioblastoma, an aggressive brain tumour, includes radiotherapy combined with temozolomide. Based on a randomised trial, showing five months increased survival, TTF has been introduced in the management of patients with good performance status. Data from the Swedish national quality registry for CNS tumours have been analysed for TTF usage.
View Article and Find Full Text PDFStem Cell Reports
February 2022
Research Programs Unit, Stem cells and Metabolism and Biomedicum Stem Cell Centre, Faculty of Medicine, University of Helsinki, Helsinki 00014, Finland. Electronic address:
Conventional reprogramming methods rely on the ectopic expression of transcription factors to reprogram somatic cells into induced pluripotent stem cells (iPSCs). The forced expression of transcription factors may lead to off-target gene activation and heterogeneous reprogramming, resulting in the emergence of alternative cell types and aberrant iPSCs. Activation of endogenous pluripotency factors by CRISPR activation (CRISPRa) can reduce this heterogeneity.
View Article and Find Full Text PDFLakartidningen
June 2016
Karolinska Institutet - Department of Molecular Medicine and Surgery Stockholm, Sweden Karolinska Institutet - Department of Medicine Stockholm, Sweden.
Modern cancer therapy has noticeably improved the prognosis for various cancer diseases, but cardiovascular side effects are not uncommon, both in short and long term. The individual patient's cardiovascular risk profile affects the risk of developing side effects. Potential underestimation of this risk can lead to life-long severe cardiac disease for a patient that has been cured from cancer.
View Article and Find Full Text PDFLakartidningen
December 2013
Smittskyddsinstitutet, Vaccin, diagnostik och vaccin, Solna; Allergicentrum, Universitets-sjukhuset, Linköping.
Lakartidningen
July 2013
Karolinska universitets-sjukhuset, institutionen för kvinnors och barns hälsa, Karolinska institutet, Stockholm.
Lakartidningen
January 2011
Kliniken för endokrinologi, metabolism och diabetes, Karolinska universitets-sjukhuset, Huddinge.
Lakartidningen
November 2007
Kliniken för kärlsjukdomar, Universitets-sjukhuset MAS, Malmö.
J Neurosurg
December 2006
Department of Neurosurgery, Karolinska Universitets Sjukhuset, Stockholm, Sweden.
Object: Intracranial chondrosarcomas have a high risk of recurrence after surgery. This retrospective study of patients with intracranial chondrosarcoma was conducted to determine the long-term results of microsurgery followed by Gamma Knife surgery (GKS) for residual tumor or recurrence.
Methods: The authors treated nine patients whose median age was 36 years.
Lakartidningen
June 2005
Institutionen för medicin och vård, internmedicin, Berzelius Science Park, Universitets-sjukhuset, Linköping.
Transpl Int
March 2001
Department of Clinical Chemistry and Transfusion Medicine, Sahlgrenska Universitets Sjukhuset, 41345 Göteborg, Sweden.
Depletion of anti-pig xenoantibodies reduces cell cytotoxicity of human serum to pig endothelial cells and lymphocytes. The aim of this study was to test, in a pig kidney xenoperfusion model, the ability of soluble alpha Gal terminated disaccharides to prevent the hyperacute rejection process in an organ. Porcine kidneys were perfused with whole human blood lacking saccharide and blood supplemented with Gal alpha 1-3GAL, Gal alpha 1-2Gal and lactose.
View Article and Find Full Text PDFUrology
May 1999
Department of Urology, Sahlgrenska Universitets Sjukhuset/Ostra, Göteborg, Sweden.
Objectives: To determine whether the volume of prostatic adenomas as assessed by transrectal ultrasound (TRUS) influenced the outcome after transurethral resection of the prostate (TURP).
Methods: TRUS with total prostate and transition zone (TZ) volume determinations was performed preoperatively in 298 consecutive patients undergoing TURP for benign prostatic hyperplasia without prior urodynamic evaluation. Postoperatively, the outcome of surgery was stated as excellent (no or minor remaining symptoms), improved (but with some remaining symptoms), or failure (the same or aggravated symptoms) according to a patient-administered questionnaire.
Lakartidningen
June 1998
Kirurgiska kliniken, Sahlgrenska Universitets-sjukhuset, Göteborg.
Findings in large randomised studies in Europe and America show that colorectal cancer mortality can be reduced by faecal occult blood screening. Moreover, in the American study it was shown for the first time that the risk of colorectal cancer is reduced by removal of benign polyps larger than 9 mm. Partly as a result of uncontrolled studies showing repeat examination with the rigid rectoscope and removal of benign adenomas to reduce the risk of cancer, flexible sigmoidoscopy has been adopted in two controlled studies, one British the other American, though the problem remains of diagnosing the 30-40 per cent of tumours that are inaccessible to the sigmoidoscope.
View Article and Find Full Text PDFLakartidningen
March 1998
Barnmedicinska kliniken, Sahlgrenska Universitets-sjukhuset/Ostra, Göteborg.
Lakartidningen
August 1997
Sektionen för gastroenterologi och hepatologi, medicinska kliniken, Universitets-sjukhuset i Lund.
Lakartidningen
July 1997
Alkohol-och narkotikakliniken, Universitets-sjukhuset MAS, Malmö.
Lakartidningen
May 1997
Kvinnokliniken, Sahlgrenska universitets-sjukhuset/Ostra, Göteborg.
Lakartidningen
February 1997
Avdelningen för klinisk farmakologi, Universitets-sjukhuset i Linköping.
Lakartidningen
October 1996
plastikkirurgiska kliniken, Universitets-sjukhuset MAS, Malmö.
Lakartidningen
August 1996
Universitets-sjukhuset, Linköping.